Total Pharmacy |

Hashim Zaibak, PharmD, CEO of Hayat Pharmacy, discussed how immunization services at his pharmacy locations have evolved since the COVID-19 pandemic.

For biosimilar, generic, and branded medications, Cencora researchers conducted a report detailing growth in formulary exclusions among the 3 largest pharmacy benefit managers in the US.

JD Power released its 2025 US Pharmacy Study detailing customer satisfaction with brick-and-mortar, mail-order, supermarket, and mass-market retail pharmacies.

Researchers explore factors influencing pharmacists' willingness to provide medication takeback services, highlighting the need for improved disposal practices and education.

With expertise into the growing issue of pharmacy deserts, Michael Murphy, PharmD, MBA, discussed exactly what patients are losing when their community no longer has pharmacy access.

Michael Murphy, PharmD, MBA, joined Drug Topics to present his ideas for correcting the growing issue of pharmacy deserts and unprecedented closures across the country.

Kristen Jones, PharmD, discusses leadership strategies in pharmacy management that prioritize emotional intelligence and communication for enhanced team performance and patient care.

Pharmacy professionals evolve into strategic leaders, mastering emotional intelligence and management skills to navigate complex workplace dynamics and enhance patient care.

Kristen Jones, PharmD, discusses challenging traditional workplace paradigms by emphasizing the human element in pharmaceutical operations.

Senators Warner and Thune reintroduced the ECAPS legislation improving both seniors’ access to care and pharmacists’ ability to get reimbursed for clinical services.

Kristen Jones, PharmD, discusses pharmacists as leaders at McKesson ideaShare 2025.

With the company’s dedication to providing crucial data for pharmacy stakeholders, IQVIA’s Lead Research Director Michael Kleinrock discussed the current trends in patients’ medication use.

This episode introduces the hosts and explores key legal issues facing independent pharmacies, including PBM terminations and state board compliance.

Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.

Addressing harassment, strengthening leadership, and involving frontline pharmacy staff in decision-making are key steps toward a healthier, more supportive work environment.

With an emphasis on the factors that differentiate the future roles of pharmacists, researchers sought to better understand the career intentions of pharmacy students.

In part 4 of our interview with Michael Kleinrock, lead director of research at IQVIA, he discussed how trends in medication use are currently impacting pharmacy businesses.

Using the Q Methodology to account for subjectivity in responses, pharmacists self-identified their professional identities.

Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy.

IQVIA’s Lead Director of Research Michael Kleinrock discusses how federal policy has been impacting prescription drug costs in the US and where those trends are expected to go.

Brooklyn Morgan, PharmD, discusses the transformation of pharmacy practice from a regulatory model to a more flexible approach.

Tamara McCants, PharmD, president of NPhA, and Tazche Turner, PharmD, national president of SNPhA, discuss what to expect at this year’s meeting.

Thomas Sherrer, PharmD, emphasizes teamwork and technology in inventory management to enhance patient safety and reduce medication errors.

Thomas Sherrer, PharmD, advocates for a team-driven, tech-enhanced approach to pharmacy inventory management, boosting patient care and operational efficiency.